CAS 500538-94-3

N1,N4-Bis[3-(1H-benzimidazol-2-yl)phenyl]-1,4-benzenedicarboxamide

Description:

N1,N4-Bis[3-(1H-benzimidazol-2-yl)phenyl]-1,4-benzenedicarboxamide, with the CAS number 500538-94-3, is a synthetic organic compound characterized by its complex structure, which includes multiple aromatic rings and amide functional groups. This compound features two benzimidazole moieties attached to a central benzene ring, which is further substituted with carboxamide groups. Its molecular structure contributes to its potential applications in various fields, including pharmaceuticals and materials science, due to its ability to engage in π-π stacking interactions and hydrogen bonding. The presence of the benzimidazole units may impart biological activity, making it of interest in medicinal chemistry for the development of novel therapeutic agents. Additionally, the compound's solubility, stability, and reactivity can be influenced by the substituents on the aromatic rings, which may affect its performance in specific applications. Overall, this compound exemplifies the intricate design often found in organic chemistry, where structural features are tailored for desired properties and functions.

Formula: C₃₄H₂₄N₆O₂

InChI: InChI=1S/C34H24N6O2/c41-33(35-25-9-5-7-23(19-25)31-37-27-11-1-2-12-28(27)38-31)21-15-17-22(18-16-21)34(42)36-26-10-6-8-24(20-26)32-39-29-13-3-4-14-30(29)40-32/h1-20H,(H,35,41)(H,36,42)(H,37,38)(H,39,40)

InChI key: InChIKey=WSXIJTIFOWCMIQ-UHFFFAOYSA-N

SMILES: N(C(=O)C1=CC=C(C(NC2=CC(=CC=C2)C=3NC=4C(N3)=CC=CC4)=O)C=C1)C=5C=C(C=6NC=7C(N6)=CC=CC7)C=CC5

Synonyms:

• N1,N4-Bis[3-(1H-benzimidazol-2-yl)phenyl]-1,4-benzenedicarboxamide
• NSC 61610
• 1,4-Benzenedicarboxamide, N,N′-bis[3-(1H-benzimidazol-2-yl)phenyl]-
• NCI 61610
• 1,4-Benzenedicarboxamide, N1,N4-bis[3-(1H-benzimidazol-2-yl)phenyl]-

NSC61610

CAS: 500538-94-3

NSC61610 is a regulatory molecule that is a cyclic peptide. It has shown activity index in the range of 1-2, which indicates that it is active against autoimmune diseases, oncostatin and cancer. NSC61610 also has antiviral resistance and bowel disease properties, as well as being active against infectious diseases like HIV. The structure of this compound consists of two hexapeptides: lysine-alanine-lysine and methionine-glycine-methionine. Synthetase activity has been observed in both prokaryotic and eukaryotic systems, so it can be synthesized by bacteria or animals. NSC61610 may be useful for the treatment of inflammatory bowel disease due to its ability to inhibit synthetase activity in cells of the intestinal mucosa. It also has anti-inflammatory effects due to inhibition of cyclooxygenase enzymes COX1 and COX2.

Formula: C₃₄H₂₄N₆O₂

Purity: Min. 95%

Molecular weight: 548.6 g/mol

Ref: 3D-AVA53894

NSC61610

CAS: 500538-94-3

NSC61610 is anti-inflammatory that activates PPARγ in vitro via LANCL2 and adenylate cyclase/cAMP-dependent pathways, thereby improving experimental colitis.

Formula: C₃₄H₂₄N₆O₂

Purity: 98%

Color and Shape: Solid

Molecular weight: 548.59

Ref: TM-T28207